fingolimod hydrochloride has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dumont, AG; Reynoso, DG; Trent, JC | 1 |
1 other study(ies) available for fingolimod hydrochloride and Gastrointestinal Stromal Neoplasm
Article | Year |
---|---|
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers -- Letter.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Fingolimod Hydrochloride; Gastrointestinal Stromal Tumors; Humans; Immunosuppressive Agents; Inhibitory Concentration 50; Mice; Mutation; Propylene Glycols; Protein Phosphatase 2; Proto-Oncogene Proteins c-kit; Sphingosine | 2011 |